Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 1.09 is 64% above its 2-year average of 0.67, near the high end of its 2-year range (0.00–1.17).
As of the fiscal period ended Tuesday, June 30, 2026. 2.34% above its 12-month average of 1.07.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.09.
DEBT TO EQUITY RATIO
1.09
DEBT TO EQUITY RATIO AVG TTM
1.07
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.34%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+59.46%
vs the sector median at left
Market Cap
$26.93B
Debt to Equity Ratio
0.85
TTM Avg
1.00
3Y Avg
0.92
5Y Avg
0.85
Market Cap
$26.37B
Debt to Equity Ratio
164.70
TTM Avg
48.23
3Y Avg
26.06
5Y Avg
17.96
Market Cap
$26.08B
Debt to Equity Ratio
0.79
TTM Avg
0.87
3Y Avg
0.78
5Y Avg
0.74
Market Cap
$28.96B
Debt to Equity Ratio
0.92
TTM Avg
1.04
3Y Avg
1.09
5Y Avg
0.74
Market Cap
$25.23B
Debt to Equity Ratio
0.10
TTM Avg
0.12
3Y Avg
0.12
5Y Avg
0.13
Market Cap
$24.40B
Debt to Equity Ratio
0.01
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $27.38B | 1.09 | 1.07 | N/A | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $26.93B | 0.85 | 1.00 | 0.92 | 0.85 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.37B | 164.70 | 48.23 | 26.06 | 17.96 |
| Labcorp Holdings Inc. (LH)vs › | $26.08B | 0.79 | 0.87 | 0.78 | 0.74 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.96B | 0.92 | 1.04 | 1.09 | 0.74 |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.23B | 0.10 | 0.12 | 0.12 | 0.13 |
| Incyte Corporation (INCY)vs › | $24.40B | 0.01 | 0.01 | 0.01 | 0.01 |
| BioNTech SE (BNTX)vs › | $24.15B | 0.02 | 0.01 | 0.01 | 0.04 |
| Zoetis Inc. (ZTS)vs › | $30.74B | 2.93 | 2.13 | 1.86 | 1.81 |
| Waters Corporation (WAT)vs › | $31.18B | 0.35 | 0.76 | 1.73 | 2.93 |
Debt/Equity
1.09
Current Ratio
4.33
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 1.09 |
| 2026-03-31 | 1.12 |
| 2025-12-31 | 1.17 |
| 2025-09-30 | 0.97 |
| 2025-06-30 | 0.98 |
| 2025-03-28 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |